Your browser doesn't support javascript.
loading
Comp34 displays potent preclinical antitumor efficacy in triple-negative breast cancer via inhibition of NUDT3-AS4, a novel oncogenic long noncoding RNA.
Hao, Qiongyu; Wang, Piwen; Dutta, Pranabananda; Chung, Seyung; Li, Qun; Wang, Kun; Li, Jieqing; Cao, Wei; Deng, Wenhong; Geng, Qing; Schrode, Katrina; Shaheen, Magda; Wu, Ke; Zhu, Donghui; Chen, Qiao-Hong; Chen, Guanglin; Elshimali, Yahya; Vadgama, Jay; Wu, Yong.
Affiliation
  • Hao Q; Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, 90095, USA.
  • Wang P; Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, 90095, USA.
  • Dutta P; Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, 90095, USA.
  • Chung S; Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, 90095, USA.
  • Li Q; Department of Oncology, Shanghai East Hospital, Tongji University School of Medicine, 200120, Shanghai, China.
  • Wang K; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, 510080, Guangzhou, China.
  • Li J; Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, 90095, USA.
  • Cao W; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital & Guangdong Academy of Medical Sciences, 510080, Guangzhou, China.
  • Deng W; Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, 90095, USA.
  • Geng Q; Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, 90095, USA.
  • Schrode K; Department of General Surgery, Renmin Hospital of Wuhan University, 430060, Wuhan, China.
  • Shaheen M; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, 430060, Wuhan, China.
  • Wu K; Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, 90095, USA.
  • Zhu D; Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, 90095, USA.
  • Chen QH; Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, 90095, USA.
  • Chen G; Department of Biomedical Engineering, Stony Brook University, Stony Brook, NY, 11794, USA.
  • Elshimali Y; Department of Chemistry, California State University, Fresno, 2555 E. San Ramon Avenue, M/S SB70, Fresno, CA, 93740, USA.
  • Vadgama J; Department of Chemistry, California State University, Fresno, 2555 E. San Ramon Avenue, M/S SB70, Fresno, CA, 93740, USA.
  • Wu Y; Division of Cancer Research and Training, Department of Internal Medicine, Charles Drew University of Medicine and Science, David Geffen UCLA School of Medicine and UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, 90095, USA.
Cell Death Dis ; 11(12): 1052, 2020 12 11.
Article in En | MEDLINE | ID: mdl-33311440
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Curcumin / RNA, Long Noncoding / Triple Negative Breast Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Cell Death Dis Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Curcumin / RNA, Long Noncoding / Triple Negative Breast Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Cell Death Dis Year: 2020 Document type: Article Affiliation country: Country of publication: